Developmental Fluoxetine Exposure Normalizes the Long-Term Effects of Maternal Stress on Post-Operative Pain in Sprague-Dawley Rat Offspring by Knaepen, L. (Liesbeth) et al.
Developmental Fluoxetine Exposure Normalizes the
Long-Term Effects of Maternal Stress on Post-Operative
Pain in Sprague-Dawley Rat Offspring
Liesbeth Knaepen1, Ine Rayen2, Thierry D. Charlier3, Marianne Fillet4, Virginie Houbart4, Maarten van
Kleef1, Harry W. Steinbusch2, Jacob Patijn1, Dick Tibboel3, Elbert A. Joosten1, Jodi L. Pawluski2,3*
1University Pain Center Maastricht, Department of Anesthesiology/Pain Management, Maastricht University Medical Center, Maastricht, The Netherlands, 2 School for
Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands, 3University of Liege, GIGA-Neurosciences, Lie`ge, Belgium, 4 Laboratory of Analytical
Pharmaceutical Chemistry, Department of Pharmacy, CIRM, University of Lie`ge, Lie`ge, Belgium, 5 Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia,
Rotterdam, The Netherlands
Abstract
Early life events can significantly alter the development of the nociceptive circuit. In fact, clinical work has shown that
maternal adversity, in the form of depression, and concomitant selective serotonin reuptake inhibitor (SSRI) treatment
influence nociception in infants. The combined effects of maternal adversity and SSRI exposure on offspring nociception
may be due to their effects on the developing hypothalamic-pituitary-adrenal (HPA) system. Therefore, the present study
investigated long-term effects of maternal adversity and/or SSRI medication use on nociception of adult Sprague-Dawley rat
offspring, taking into account involvement of the HPA system. Dams were subject to stress during gestation and were
treated with fluoxetine (26/5 mg/kg/day) prior to parturition and throughout lactation. Four groups of adult male offspring
were used: 1. Control+Vehicle, 2. Control+Fluoxetine, 3. Prenatal Stress+Vehicle, 4. Prenatal Stress+Fluoxetine. Results show
that post-operative pain, measured as hypersensitivity to mechanical stimuli after hind paw incision, was decreased in adult
offspring subject to prenatal stress alone and increased in offspring developmentally exposed to fluoxetine alone.
Moreover, post-operative pain was normalized in prenatally stressed offspring exposed to fluoxetine. This was paralleled by
a decrease in corticosteroid binding globulin (CBG) levels in prenatally stressed offspring and a normalization of serum CBG
levels in prenatally stressed offspring developmentally exposed to fluoxetine. Thus, developmental fluoxetine exposure
normalizes the long-term effects of maternal adversity on post-operative pain in offspring and these effects may be due, in
part, to the involvement of the HPA system.
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Introduction
Early life events can significantly influence the development of
the nociceptive network and pain responses in later life [1].
Recently, maternal adversity in the form of perinatal stress and
depression has been shown to affect not only the mother, but also
the neonate. Moreover, perinatal maternal stress has been linked
to increased nociceptive responses in the newborn [2–4]. For
example, exposure to prenatal maternal stress increases a baby’s
response to a painful heel prick [2]. Perinatal maternal depression,
often a stress-related disease, is a major condition which affects
20% of women [5]. However, little is known about the long-term
impact of maternal adversity on nociception in offspring.
Preclinical work has shown that perinatal maternal stress results
in increased pain sensitivity in adult rat offspring [6,7]. Underlying
mechanisms for such long-term effects of maternal adversity on
nociception in later life are rather unknown. Clinical and
preclinical studies have shown that intra-uterine exposure to high
levels of glucocorticoids or maternal stress affect stress responses in
offspring [2,8–11]. Furthermore, a dysregulated hypothalamic-
pituitary-adrenal (HPA) system has been related to alterations in
pain responses [12,13]; decreased cortisol levels have been linked
to increased pain symptoms in patients with chronic pain [14].
Glucocorticoid receptors (GRs) are involved in pain processing
given their presence on nociceptive neurons in the spinal cord
[15,16]. Moreover, these neurons show signs of activation when C-
fibers are noxiously stimulated [17] and intrathecal application of
a GR antagonist has been shown to attenuate neuropathic pain
[18].
Selective serotonin reuptake inhibitor (SSRI) medications, e.g.
fluoxetine, are the most common treatment for maternal
depression and are prescribed to 5–10% of pregnant mothers
[19–21]. SSRIs cross the placenta [22] and are transferred, via
breast milk [23], to the infant. Developmental SSRI exposure
increases serotonin (5-HT) levels in offspring and may affect the
development of the 5-HT-pain inhibitory circuit [1]. Indeed,
recent clinical research has shown that infants perinatally exposed
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to SSRIs have blunted pain responses to a heel prick at two days
and two months after birth [24,25], demonstrating an involvement
of SSRIs on offspring nociception. Besides having a direct effect on
the nociceptive system, 5-HT levels play a prominent role in the
development of the HPA-axis [26,27] and perinatal exposure to
SSRIs can alter the developing HPA system [28,29]. Therefore
SSRIs may impact the developing nociceptive system indirectly via
altering the HPA-axis.
The objective of this study was to investigate the effect of
maternal stress on nociception in adult offspring. In turn, because
SSRIs are commonly used for treatment of maternal stress-related
disorders, we investigated the effect of developmental exposure to
SSRIs on nociception in adult male offspring taking into account
the involvement of the HPA system on these effects. To do this
prenatally stressed offspring were exposed to fluoxetine during the
perinatal period. Offspring were tested for basal nociception and
post-operative nociception after hind paw incision during adult-
hood. Moreover, circulating corticosterone and corticosteroid
binding globulin (CBG) levels were investigated. This work
provides important information on the long-term impact of
developmental exposure to maternal adversity and SSRI treat-
ment on nociception and sheds light on the underlying physiology
related to these changes.
Materials and Methods
Ethical Statement
All animal experiments were performed in accordance with the
European Directive for the Protection of Vertebrate Animals Used
for Experimental and Other Scientific Purposes (86/609/EEC)
and adhered to the Guidelines for the Care and Use of Mammals
in Neuroscience and Behavioral Research (National Research
Council 2003). The protocol was approved by the Animal Ethics
Board of Maastricht University in accordance with Dutch
governmental regulations (approval IDs: DEC 2008-184 and
DEC 2010-150). All surgery was performed under isoflurane
anesthesia, and all efforts were made to minimize suffering.
Animals
In this experiment a total of 20 Sprague-Dawley rats (Charles
River Laboratories, France) were used. The animals were housed
in a temperature (19–24uC) and humidity (55615%) conditioned
room with a 12:12 light/dark schedule (lights on at 8:00 a.m.) with
ad libitum access to tap water and rat chow. Breeding of the dams
took place by putting one female and one male together in a wire
mesh cage. Release of a vaginal plug was considered as gestation
day (G) 0.
On G14, dams were randomly assigned to stress (N=9) or
control (N=11) groups. Dams in the stress group were individually
restrained three times a day (at 8:00 a.m., 11:30 a.m. and
15:30 p.m.) for 45 min in a plastic cylinder under bright light on
G14-G20 [11,30,31]. Stress during this period of pregnancy can
result in postpartum depressive-like behavior in the dam [32,33].
The day after the last stress exposure (G20) dams were randomly
assigned to one of the two treatment groups: fluoxetine (two doses
of 5 mg/kg per day) or vehicle, resulting in a total of four groups of
dams: 1. Control+Vehicle (CV; N=5), 2. Control+Fluoxetine (CF;
N=6), 3. Prenatal Stress+Vehicle (SV; N=4), 4. Prenatal
Stress+Fluoxetine (SF; N=5). After weaning at P21, two male
offspring per litter were housed together in standard cages and
used for behavioral testing, resulting in group sizes of N=8–12.
Offspring were weighed at the age of 8 weeks and at 1, 7 and 9
days after surgery. For a timeline of the experiment see Figure 1.
Fluoxetine treatment
During G14–20 dams were trained for oral ingestion of the
medication treatment. Dams were fed 1/9th of a vanilla wafer-
cookie (Croustifondante, Delacre, Belgium), filled with saline [34].
During feeding dams were not separated from the litter. At G21
treatment was started and dams were fed two times per day (at
9:00 a.m. and 14:00 p.m.) a cookie filled with fluoxetine (Flagron,
Belgium) dissolved in vehicle (50% propylenediol in saline; 5 mg/
kg) or vehicle solution. Since maternal restraint stress results in
postpartum depressive-like behavior, as mentioned before, dams
were treated with fluoxetine from G21 until P21. Oral adminis-
tration via a cookie was preferred instead of oral gavage or
injections, which might induce pain and stress in the dam/litter.
Since fluoxetine and its active metabolite norfluoxetine are passed
to offspring via lactation [35], fluoxetine and norfluoxetine levels
were determined at several time-points during lactation (see
section 2.3). Exposure of offspring to fluoxetine occurred during a
stage of neural development in rodents analogous to that of the
third trimester in humans [36], when nociceptive fibers are present
but in an immature stage [1].
Fluoxetine and norfluoxetine determination
To determine fluoxetine and norfluoxetine concentrations in rat
serum, blood samples were collected by quick decapitation from
culled pups on P1, from one female pup on P7 and P14, and from
the dam, one female and one male pup at P21. Although,
behavioral testing was performed only in male offspring, female
offspring were used for drug determinations to provide an
indication of the drug levels in the pups at this age. This took
place in every litter, where surplus pups were available. Blood
samples were centrifuged at 10 0006g for 10 minutes and serum
was collected. Drug concentrations were determined from serum
using liquid chromatography coupled with mass spectrometry
(LC-Chip-MS/MS) was used as previously described [37,38].
Briefly, the chromatographic separation was achieved on a 1200
series LC-chip system (Agilent Technologies, Germany) using a
Ultra High Capacity chip including a 500 nL trapping column
and a 150 mm675 mm analytical column, both packed with a
Zorbax 80SB 5 mm C18 phase (Agilent Technologies). The mobile
phase was composed of H2O/FA (100:0.1, v/v) (A) and ACN/
H2O/FA (90:10:0.1, v/v/v) (B) and used in gradient elution
mode. Mass spectrometric detection was performed using a 6340
Ion Trap equipped with a nanoelectrospray ionization source
operating in positive mode (Agilent Technologies, Waldbronn).
Finally, an Oasis mElution MCX 96-well plate (Waters, UK) was
used to prepare the samples for the analysis. 25 mL serum was
needed per experiment and all conditions were performed in
duplicate and back-calculated using a calibration curve. Mean
drug levels show the presence of fluoxetine and norfluoxetine in
offspring serum at the age of P1, P14 and P21 (Table 1) (N=7–
11/group). This shows that fluoxetine is transferred to offspring via
lactation.
Nociception behavioral tests
Sensitivity of offspring to mechanical stimuli and thermal stimuli
was tested at several time points: basal nociception was tested
during development at 4 weeks of age and at the young-adult age
of 8 weeks and post-operative hypersensitivity was tested daily in
young-adult rats until 9 days after surgery; (Fig. 1). Sensitivity to
mechanical stimuli was determined by measuring paw withdrawal
thresholds (PWT) using plantar application of 10 von Frey
monofilaments (North Coast Medical, Inc., California, USA) with
logarithmically incremental stiffness (0.166, 0.407, 0.692, 1.202,
2.041, 3.63, 5.495, 8.511, 15.136 and 28.84 g). Animals were
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placed in Plexiglass cages on an elevated wire mesh floor and
allowed to adapt to the cage for 30 min before testing. Starting
with the lowest filament, each filament was applied five times with
a duration of one second and inter-application interval of a few
seconds to the plantar paw surface. Maximal applied force was
defined by maximal withdrawal, i.e. when the animal showed five
withdrawal responses. The mechanical force resulting in a 50%
withdrawal frequency was considered the PWT and was calculated
from a sigmoid curve (withdrawal frequency per filament vs. force
log applied) by regression analysis (GraphPad Prism Version 4.00,
CA, USA) [39].
Thermal sensitivity was determined using the Hargreaves
thermal plantar algesia apparatus at the age of 5 and 8 weeks
(Ugo Basile, Collegeville, PA, USA). After an adaptation period of
about 30 minutes, an infrared laser beam was placed at the mid-
plantar surface of the hind paw. The apparatus measures the paw
withdrawal latency (PWL) from the infrared source (intensity of 70)
to the nearest 0.1 s. Mean PWL from three measurements per paw
(ten minute intervals) was measured with a cut-off time of 20 s. For
post-operative testing of hypersensitivity, the Hargreaves appara-
tus was not used, since mechanical hypersensitivity is reported to
be the main outcome for post-incision pain [40]. The researcher
performing behavioral testing was blinded to grouping of the
animals.
Locomotor activity
Locomotor activity was investigated at 8 weeks of age in
offspring to ensure there were no gross differences in locomotion
between groups. Animals were placed individually in the center of
a 50 cm6100 cm glass arena and their activity was recorded for
10 minutes. All animals were tested between 2:00 and 5:00 p.m. A
video-tracking system (Anymaze, Stoelting) was used to measure
the distance the animals travelled in the arena. The apparatus was
cleaned with 70% ethanol and dried between rats.
Post-operative pain at the age of 8 weeks: plantar hind
paw incision
Plantar hind paw incision was performed at the age of 8 weeks,
a young-adult age at which alterations in the nociceptive network
organization and in hind paw incision pain have been evidenced
following neonatal pain exposure [41]. After baseline nociceptive
and locomotor activity testing, all male offspring received an injury
to the left hind paw, i.e. plantar hind paw incision as a model for
post-operative pain [40]. Animals were anesthetised with 3–5%
isoflurane (Abbott Laboratories Ltd., Kent, U.K.), mixed with air
enriched with 100% oxygen at a constant flow rate of 250 ml/
min. Body temperature was maintained at 37.5uC using an
automatic heating pad. After making a61 cm longitudinal incision
through the plantar skin and fascia, the plantaris muscle was
elevated and incised at the midline as described previously [40].
Two mattress-sutures with 5–0 nylon on a PS-2 needle (Ethicon,
San Lorenzo, P.R.) were used to close the wound. Hypersensitivity
to mechanical stimuli after surgery was determined daily by
measuring PWT to von Frey filaments until 9 days after surgery.
Corticosterone analysis
To investigate effects of maternal stress and developmental
fluoxetine on corticosterone levels in offspring in basal conditions
and at one and seven days after hind paw incision, blood samples
were collected from the tail vein. Blood samples were centrifuged
at 10 0006g for 10 minutes and serum was collected. A
commercially available corticosterone RIA kit (Corticosterone
I125 for rats and mice, MP Biomedicals, NY, USA) was used to
determine total corticosterone levels in duplicate serum samples.
Interassay variability was 7.4%. The lowest detection limit of the
kit was 7.7 ng/mL
Figure 1. Schematic overview of the study. Pregnant dams were stressed three times per day for 45 minutes from gestational day (G) 14 until
G20. The stressor consisted of restraint in a plastic cylinder and exposure to bright light. Fluoxetine was administered orally to the dams from G21
until the day of weaning at three weeks of age (3 w). After weaning, 2 male offspring from control/vehicle, control/fluoxetine, stress/vehicle and
stress/fluoxetine dams were subjected to behavioral testing (N=8/12 per group). Their basal paw withdrawal thresholds (PWT) to mechanical stimuli
and paw withdrawal latencies (PWL) to heat stimuli were tested at 4 weeks, i.e. a juvenile age during development, and at 8 weeks, when animals
were at a young adult age. Also, a locomotor activity (LA) test was performed at the age of 8 weeks. One day after the last behavioral basal test at 8
weeks, all offspring received an incision of the left hind paw, after which PWT were measured daily until 9 days post incision (DPI9). To measure serum
levels of corticosterone and corticosterone binding globulin (CBG), tail vein blood was withdrawn at the age of 5 and 8 weeks and at DPI1 and DPI7
(+).
doi:10.1371/journal.pone.0057608.g001
Table 1. Mean (6SEM) serum levels of fluoxetine (ng/mL) and norfluoxetine (ng/mL) during the postnatal period. (P = postnatal
day).
P1 P7 P14 Male P21 Female P21 Mom P21
Fluoxetine (ng/mL) 19.46 (622.98) 2.44 (62.90) 1.76 (65.38) 2.07 (63.98) 1.52 (62.47) 30.65 (659.14)
Norfluoxetine (ng/mL) 83.01 (614.45) 16.32 (617.33) 11.35 (619.26) 27.41 (621.03) 33.61 (621.26) 184.63 (6104.66)
(N= 7–11).
doi:10.1371/journal.pone.0057608.t001
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Corticosterone binding capacity
Corticosterone binding capacity was determined by measuring
the level of CBG according to an earlier described method
[42,43]. Specifically bound CBG counts were calculated by
subtracting the non-specific background counts from the average
of total bound CBG counts. Interassay variability was 7.3%.
Statistical analysis
All data shown were presented as means6standard error of the
mean (SEM). Two-way analysis of variance tests (ANOVA) were
used to analyze the effect of group (condition: stress/control,
treatment: fluoxetine/vehicle) as independent variables on off-
spring weight, locomotor activity outcomes, PWT, corticosterone
levels, and CBG levels as the dependent variable. Additionally, a
mixed design ANOVA was performed with condition (stress/
control) and treatment (fluoxetine/vehicle) as the independent
variables and time as the repeated measure for CBG and
corticosterone serum levels and separately for each paw for PWTs
comparisons. Post hoc comparisons were performed for further
analysis of single effect comparisons and utilized the Fischer’s least
significant difference (LSD) test. Correlations were conducted
between CBG levels and PWT (log transformed). P#0.05 was
considered to be statistically significant (Statistica Version 9).
Results
Offspring weight
Total litter weight and the number of male and female pups was
not significantly affected by maternal stress and/or fluoxetine
exposure (0.17#P#0.97) (Table 2). There was a significant main
effect of time (F(3, 108) = 592.36, P=0.001) for all groups (Table 3)
indicating that all animals gained weight during the experiment.
However, no effect of stress or treatment was observed
(0.38#P#0.87).
Locomotor activity
To exclude locomotion problems, which might interfere with
nociception behavioral testing, we evaluated overall locomotion
and there was no effect of stress or treatment on the distance the
animals travelled in the open arena (0.37#P #0.74; Table 4).
Basal nociception
There was no significant difference in PWL to thermal stimuli in
offspring from mothers exposed to stress and/or fluoxetine at the
age of 4 and 8 weeks (0.21#P#0.91; Fig. 2). There were also no
statistically significant differences associated with condition or
treatment in PWT to mechanical von Frey stimuli of male
offspring at the age of 4 weeks (0.16#P#0.85; Table 5). The PWT
at the age of 8 weeks served as the baseline value for post-operative
hypersensitivity to mechanical stimuli and the analysis was
therefore performed together with the post-operative hypersensi-
tivity data (Fig. 3). At the age of 8 weeks, developmental fluoxetine
exposure decreased PWT to von Frey stimuli (P=0.0198; Fig. 3).
However, since this decrease was only observed at the left
(ipsilateral to the hind paw incision), but not at the right
(contralateral) hind paw and was not observed at the age of 4
weeks, it is considered as not consistent.
Post-operative nociception
The effect of hind paw incision on PWT to mechanical stimuli
was measured from one day post incision (DPI1) until DPI9. There
was a significant interaction effect of time*condition*treatment
(F(9, 324) = 2.41, P=0.012) on PWT of the incised, i.e. ipsilateral,
paw (Fig. 3A). CF offspring had the highest sensitivity to
mechanical stimuli, i.e. the lowest PWT after surgery. Post hoc
tests showed that CF offspring had lower PWT than SF offspring
(b P=0.000095) and CV offspring (c P=0.019) at the baseline
(BL), i.e. the day before surgery. Further post hoc tests showed that
after incision CF offspring had lower PWT than SV offspring
at DPI1, DPI3, DPI4, DPI6, DPI7, DPI8 and DPI9
(DPI1: a P=0.019, DPI3: a P=0.015, DPI4: a P=0.0080,
DPI6: a P=0.0076, DPI7: a P=0.000011, DPI8: a P=0.0052,
DPI9: a P=0.042). Also, CF offspring had lower PWT than SF
offspring at DPI7 (b P=0.00052) and DPI8 (b P=0.000020) and
then CV offspring at DPI7 (c P=0.00073). Moreover SV had
higher PWT than all other groups at DPI5 (d 0.002#P#0.009).
Table 2. Mean (6SEM) weights (g) of litters and number of male and female pups on postnatal day (PD 1).
CV CF SV SF
Litter weight at PD1 (g) 96.92 (65.35) 97.25 (64.54) 101.60 (610.55) 92.00 (67.00)
No. of males 6.80 (60.49) 5.83 (60.87) 5.50 (60.65) 6.40 (60.87)
No. of females 6.60 (60.68) 7.83 (60.75) 8.25 (61.70) 6.60 (60.93)
CV: control vehicle, CF: control fluoxetine, SV: stress vehicle, SF: stress fluoxetine, (N= 4–6/group).
doi:10.1371/journal.pone.0057608.t002
Table 3. Mean (6SEM) weights (g) of male offspring.
Group 8 w weight (g) DPI1 weight (g) DPI7 weight (g) DPI9 weight (g)
CV 323.98 (66.54) 337.16 (66.79) 366.71 (66.85) 376.75 (66.28)
CF 307.23 (67.60) 322.39 (65.77) 355.83 (64.90) 365.08 (65.02)
SV 321.11 (67.52) 331.94 (68.11) 366.71 (69.36) 376.75 (69.81)
SF 303.62 (610.86) 315.98 (611.69) 348.13 (611.59) 365.00 (611.67)
A statistically significant main effect of time was observed (F(3, 108) = 592.36, P=0.001). DPI: days post incision, 8 w: 8 weeks, CV: control vehicle, CF: control fluoxetine,
SV: stress vehicle, SF: stress fluoxetine (N= 8–12/group).
doi:10.1371/journal.pone.0057608.t003
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Also, there was a main effect of condition (F(1, 36) = 16.18,
P=0.00028) and treatment (F(1,36) = 10.19, P=0.0029). There
were no significant differences in contralateral PWT at any of the
time points measured (0.13#P#0.79; Fig. 3B).
We also calculated the area under the curve (AUC) of the post-
incision hypersensitivity (Fig. 3C-D). There was a significant main
effect of condition on the AUC of the ipsilateral paw, with
offspring exposed to maternal stress (SV and SF groups) showing
higher AUC compared to offspring from control mothers (CV and
CF groups) (F(1, 36) = 18.57, #P=0.00012; Fig. 3C). Also, there
was a significant main effect of treatment with developmental
fluoxetine resulting in lower AUC compared to offspring exposed
to vehicle treatment (F(1, 36) = 13.83, ##P=0.00068; Fig. 3C). A
trend toward a main effect of condition was observed on the
contralateral paw with control animals having a tendency for
lower AUC values ($P=0.056; Fig. 3D).
Corticosterone levels
There was a significant time*condition interaction effect (F(3,
72) = 2.80, P=0.046), with control offspring having higher
corticosterone levels at the 8 week time point relative to stress
offspring, regardless of fluoxetine exposure (*0.00018#P#0.019;
Fig.4A). There was a significant main effect of time (F(3,
72) = 3.11, P=0.032) on serum corticosterone levels. Post hoc
correction showed that the main effect of time was confined to the
increase in serum corticosterone levels at the age of 8 weeks (#
0.0057#P#0.028; Fig. 4A). Analysis of the AUC of the
corticosterone curves, showed no significant differences
(0.16#P#0.26; Fig. 4B).
CBG levels
A statistically significant interaction effect of condition*treat-
ment was noted (F(1, 24) = 7.08, P=0.014; Fig. 4C). Post hoc tests
showed that SV offspring had lower serum CBG levels than CV
and SF offspring (* 0.031#P#0.045; Fig. 4C). There was a main
effect of time (F(3, 72) = 9.01, P=0.000038; Fig. 4C) which was
mainly attributable to the decrease in serum CBG levels at DPI1
(# P=0.0020; Fig. 4C). In the AUC, there was a significant
interaction effect between condition and treatment (F(1,
31) = 6.89, P=0.013) for CBG values, with higher CBG serum
levels in SF offspring compared to SV offspring (* P=0.037;
Fig. 4D).
We also found significant positive correlations between CBG
levels and basal nociception in the form of paw withdrawal
thresholds (PWT) to mechanical stimuli of the ipsilateral (r=32,
P=047) and contralateral paws on week 8 (r=33, P=037) and a
tendency for a correlation in the contralateral paw on post incision
day 1 (r =31, P=051).
Discussion
The present study demonstrates that prenatal maternal stress
decreases, and developmental fluoxetine exposure increases, the
intensity of post-operative hypersensitivity to mechanical stimuli in
adult male offspring. Interestingly, post-operative hypersensitivity
was normalized in offspring exposed to maternal stress in
combination with fluoxetine exposure during development.
Moreover, these effects were, in part, linked to changes in the
HPA system.
Figure 2. Mean(±SEM) basal nociceptive paw withdrawal latency (PWL) thresholds (s) to heat stimuli. There was no effect of maternal
stress or fluoxetine on the PWL to heat stimuli at the left (A) or right hind paw (B) of male offspring at the age of 4 and 8 weeks. Also, there was no
effect of time, since there was no difference in PWL between the age of 4 and 8 weeks. CV: control vehicle, CF: control fluoxetine, SV: stress vehicle,
SF: stress fluoxetine (N= 8/12 per group).
doi:10.1371/journal.pone.0057608.g002
Table 4. Mean (6SEM) distances that the animals travelled in
the open arena at the age of eight weeks.
Group Distance (m)
CV 12.69 (60.66)
CF 13.74 (60.87)
SV 12.68 (61.26)
SF 12.20 (60.58)
There were no differences in distances between the groups. CV: control vehicle,
CF: control fluoxetine, SV: stress vehicle, SF: stress fluoxetine (N=8–12/group).
doi:10.1371/journal.pone.0057608.t004
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Prenatal stress and developmental fluoxetine exposure:
effects on post-operative pain in adult offspring
Our findings show that maternal prenatal stress decreases post-
operative hypersensitivity to mechanical stimuli in offspring at the
age of 8 weeks. Although very little work has been done in this
area, previous clinical work has shown that maternal stress can
increase pain sensitivity in later life with increased somatic pain
complaints at 18 months of age and recurrent abdominal pain in
13-year old children [3,4]. Stress exposure in preterm born
children affects their HPA-axis response to painful immunization
[44] and their HPA system dysfunction has been related to mother
behavior [45]. Previous preclinical work has also shown that
maternal restraint stress increases inflammatory pain hypersensi-
tivity in newborn and adult offspring [7,46]. Thus, in contrast to
our study, maternal stress has been shown to increase pain
sensitivity. This difference may depend on the type of pain which
is perceived, i.e. incisional pain in our study and inflammatory and
abdominal pain in the above mentioned studies. A decrease in
post-operative sensitivity to mechanical stimuli, as noted in our
study, may be beneficial and indicate a faster recovery from paw
incision. However, one study has shown that decreased post-
operative pain might be detrimental as it can result in inadequate
wound healing [47]. In the previously mentioned study, decreasing
post-operative hypersensitivity to mechanical stimuli, after hind
paw incision, with an analgesic treatment resulted in animals
continually placing weight on the incised paw and consequently
Figure 3. Mean (±SEM) PWTs in male offspring exposed to mechanical stimuli (g) after incision of the left hind paw. There was an
overall interaction effect of time*condition*treatment observed for PWT to mechanical stimuli after incision. Also main effects of condition and
treatment were observed. Significant differences were shown by post hoc correction and denoted by a, b, c, d and e symbols (A). Contralateral PWT
were not affected by paw incision (B), since there were no differences observed between the groups. Area under the curve (AUC) analysis (C) of the
ipsilateral PWT graphs in A, showed a main effect of condition (#) and a main effect of treatment (##). Contralateral AUC (D) showed a trend for a
main effect of condition with control offspring having a tendency for lower PWT than stress offspring ($). DPI: days post incision, CV: control vehicle,
CF: control fluoxetine, SV: stress vehicle, SF: stress fluoxetine (N= 8/12 per group).
doi:10.1371/journal.pone.0057608.g003
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impaired wound apposition occurred [47]. We did not measure
the degree of wound healing in the present study, but it is possible
that there were differences in the rate of wound healing between
offspring exposed to prenatal stress and control offspring.
We found that prenatally stressed offspring exposed to maternal
fluoxetine treatment had normalized post-operative hypersensitiv-
ity to mechanical stimuli. Surprisingly, we observed that develop-
mental fluoxetine exposure in the absence of prenatal stress
increased post-operative hypersensitivity to mechanical stimuli in
adult offspring. This highlights the need to investigate the effects of
these medications using appropriate models of maternal adversity
in order to draw suitable conclusions and clearly parallel the
clinical situation. It has been shown that infants from depressed
mothers treated with SSRIs have blunted pain responses at two
days and two months of age [24,25]. No other studies have
investigated the effects of developmental SSRI exposure on post-
Table 5.Mean (6SEM) PWTs to von Frey stimuli (g), reflecting
sensitivity of the hind paws to mechanical stimuli at the age
of 4 weeks.
Group Left hind paw PWT (g) Right hind paw PWT (g)
CV 12.14 (61.68) 12.12 (61.67)
CF 12.05 (61.45) 12.25 (61.45)
SV 13.92 (62.29) 13.92 (62.29)
SF 15.01 (61.23) 14.68 (61.20)
No differences were observed in PWT for the left and right hind paw between
the groups. CV: control vehicle, CF: control fluoxetine, SV: stress vehicle, SF:
stress fluoxetine (N= 8–12/group).
doi:10.1371/journal.pone.0057608.t005
Figure 4. Mean (±SEM) and AUC of serum levels of corticosterone and CBG of male offspring. A time*condition interaction effect was
observed in control offspring, but not stress offspring, having a higher corticosterone level at the 8 week time-point (A, *). There was a main effect of
time on serum corticosterone levels and post hoc corrections showed that the levels at 8 weeks were significantly higher than levels at all other time-
points (A, #). No effect of condition or treatment was observed on AUC of serum corticosterone levels (B). A condition*treatment interaction effect,
with lower serum CBG levels in SV offspring, compared to SF and CV offspring (C, *). A main effect of time was observed and post hoc correction
showed that this was attributable to the decrease in serum CBG at DPI1 (C, #). A significant interaction effect of condition*treatment was shown in
AUC of CBG serum levels, with lower AUC values for SV offspring, compared to SF offspring (D, *). DPI: days post incision, CV: control vehicle, CF:
control fluoxetine, SV: stress vehicle, SF: stress fluoxetine (N= 8/12 per group).
doi:10.1371/journal.pone.0057608.g004
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operative hypersensitivity to pain or the long-term impact of
perinatal SSRI exposure on pain sensitivity in any regard.
However, developmental exposure to buspirone, a 5-HT1A
receptor agonist, was shown to normalize the increased pain
hypersensitivity in prenatally stressed adult offspring [7]. More
research is needed to investigate how children, prenatally exposed
to SSRIs, respond to painful stimuli in later life.
Although beyond the scope of this study, it should be noted that
prenatal maternal stress and/or fluoxetine may have affected
aspects of maternal care. Although previous work by our group
has shown no marked changes in gross maternal care of offspring
with prenatal maternal stress or fluoxetine treatment [11], we have
also shown that fluoxetine exposure, but not prenatal stress,
increases arched-back nursing of pups [38]. However, it is
unknown how changes in arched-back nursing, without concom-
itant changes in licking behavior, may alter pain sensitivity in adult
offspring.
Involvement of the HPA system
In the present study we found that hind paw incision resulted in
a decrease in serum CBG levels in adult offspring. Interestingly,
offspring exposed to maternal prenatal stress alone showed overall
lower serum CBG levels compared to prenatally stressed offspring
developmentally exposed to fluoxetine and control offspring. This
CBG profile is paralleled in their post-operative pain profiles, i.e.
lower post-operative pain hypersensitivity in prenatally stressed
offspring, and suggests a potential link between the HPA system
and post-operative pain. Moreover, prenatally stressed offspring
exposed to fluoxetine show serum CBG levels which are
comparable with the levels of offspring from control mothers
and thus, these levels may parallel effects of normalization of post-
operative pain hypersensitivity by developmental fluoxetine
exposure in prenatally stressed offspring. Fluoxetine exposure
alone appeared to decrease serum CBG levels in adult offspring, as
previously described [29], but did not parallel post-operative pain
hypersensitivity. Therefore, there may be a relationship between
circulating CBG levels and post-operative pain, at least in
prenatally stressed male offspring. We did not find a significant
correlation between overall CBG levels and pain sensitivity after
paw incision. It is likely that a number of factors are mediating this
relationship and it also may be that CBG levels at the point of the
incision would better clarify the relationship between CBG and
post-operative pain sensitivity.
SSRIs increase 5-HT levels in the newborn and 5-HT levels
play a prominent role in the development of the HPA-axis [26,27]
and therefore SSRIs may impact on the nociceptive system
indirectly via the HPA-axis. Interestingly this work suggests that
serum CBG levels can be indicative of post-operative pain
hypersensitivity, but only when fluoxetine exposure is not present.
This is perhaps not surprising as clinical work has shown that the
action of antidepressant medications may act to alter CBG levels
[48]. Thus developmental exposure to SSRIs may differentially
alter the function of CBG with regards to pain sensitivity.
We did not find an effect of hind-paw incision on circulating
levels of total corticosterone levels. The absence of an effect of
surgery on corticosterone levels in the present study is in line with
previous work showing no increase in circulating serum cortico-
sterone levels at 24 hours after open thorax surgery in a rat [49].
However, in humans, increased serum cortisol levels have been
shown after major colonic and abdominal surgery [50,51].
Discrepancies between these findings may be related to the
severity of the surgical intervention that determines the increase in
circulating corticosterone levels or to the timing of blood
withdrawal after surgery.
Prenatal stress and developmental fluoxetine exposure:
effects on basal nociceptive thresholds in offspring
Besides a small effect of developmental fluoxetine on ipsilateral
PWT at 8 weeks, we did not find any significant effect of prenatal
stress and/or developmental fluoxetine exposure on basal noci-
ceptive thresholds to mechanical and thermal stimuli in juvenile
and adult male offspring. Although these parameters were
previously not specifically investigated, research has shown that
basal hypersensitivity in response to mechanical stimulation of
muscles or viscera can occur in adult offspring following repeated
postnatal stress, via maternal separation or exposure to limited
bedding material [6,52,53]. The impact of SSRIs during
development on basal sensory thresholds has not been widely
investigated. Our observation of unaltered thresholds to mechan-
ical and thermal stimuli in fluoxetine-exposed offspring is in line
with earlier findings describing unaltered thermal thresholds in
adult offspring (at P70) following oral fluoxetine administration to
non-stressed pregnant mothers [54]. However, this is in contrast
with previous work showing that administering fluoxetine directly
to neonatal pups via daily injections increased thermal threshold in
adolescent rats (at P35) [55]. Thus, basal nociception outcomes
may be dependent on the perinatal stress model, route of SSRI
administration or behavioral test used.
Conclusions
The present study is the first to investigate long-term effects of
combined prenatal maternal stress and developmental fluoxetine
exposure. We show here that both prenatal stress and develop-
mental fluoxetine exposure affect the intensity of post-operative
pain differentially in offspring at the age of 8 weeks. Maternal
stress decreases and developmental fluoxetine increases post-
operative pain hypersensitivity at this age. However, when
maternally stressed dams were treated with fluoxetine offspring
showed normal post-operative pain profiles, thus SSRI treatment
for maternal adversity may normalize nociception in adult
offspring. These changes were paralleled, in part, by modulation
of the HPA system. Clearly there is a marked long-term effect of
maternal adversity and developmental SSRI exposure on post-
operative pain in offspring. However, before conclusions can be
made about the benefits and risks of perinatal SSRI exposure on
offspring development further research is needed.
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